FindTrial
Sign In

Clinicopathological features and prognostic factors of gastric adenosquamous carcinoma

Clinicopathological features and prognostic factors of gastric adenosquamous carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062463
Enrollment
Unknown
Registered
2022-08-08
Start date
2022-08-20
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Pathological examination of gastrectomy specimens confirmed PGASC (more than 1/3 adenocarcinoma and squamous carcinoma) or GAC; 2. Or immunohistochemical results suggested that squamous carcinoma cells expressed P63 and/or P40; 3. Complete clinical data, pathological data, and follow-up information.

Exclusion criteria

Exclusion criteria: 1. Cases of squamous carcinoma of the lower esophagus invading cardia and/or fundus of stomach; 2. Gastric stump carcinoma; 3. Pregnant or lactating women; 4. History of other malignant diseases within 5 years; 5. Preoperative neoadjuvant therapy cases; 6. Cases requiring concurrent surgical treatment for other diseases.

Design outcomes

Primary

MeasureTime frame
Overall survival for 3 and 5 years;Sensitivity to chemotherapy;—

Countries

China

Contacts

Public ContactXia Xiang

Renji Hospital, Shanghai Jiao Tong University School of Medicine

xiaxiang@renji.com+86 136 5181 0863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026